Inovio Pharmaceuticals, Inc. (INO) Doubles Q2 Loss to 6c/Share; Issues Update
Tweet Send to a Friend
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q2 EPS of ($0.06), versus ($0.03) reported last year. Revenue for the quarter came ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
